Adelin, Fhezal .
HRN: 23-94-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
CEFUROXIME 750MG (VIAL)
10/22/2023
10/29/2023
IV
350mg
Q8h
Uti
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes